Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro (original) (raw)
Bold RJ, Ishizuka J, Townsend CMJ and Thompson JC (1996) All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas12: 189–195 ArticleCASPubMed Google Scholar
Bollag W, Majewski S and Jablonska S (1994) Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia8: 1453–1457 CASPubMed Google Scholar
Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante T, Sanders WH, Berjian R, Douglass HO, Martin EW and Ming Chu T (1982) Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. in vitro18: 24–34 ArticleCASPubMed Google Scholar
Colston KW (1997) Vitamin D and breast cancer: therapeutic potential of new vitamin D analogues. Vitamin D, Feldman D (ed), pp. 1107–1123, Academic Press: San Diego Google Scholar
Colston KW, James SJ, Ofori-Kuragu EA, Binderup L and Grant AG (1997) Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer76: 1017 ArticleCASPubMedPubMed Central Google Scholar
Danielsson C, Mathiasen IS, James SJ, Nayeri S, Bretting C, Hansen CM, Colston KW and Carlberg C (1997) Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem66: 552–562 ArticleCASPubMed Google Scholar
Danielsson C, Torma H, Vahlquist A and Carlberg C (2000) Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int J Cancer81: 467–470 Article Google Scholar
Dippold W, Bernhard H, Meyer zum B and schenfelde KH (1997) Chemotherapy in advanced pancreatic cancer. Int J Pancreatol21: 39–41 CASPubMed Google Scholar
El-Deriny S, O’Brien MJ, Christensen TG and Kupchik HZ (1987) Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells. Pancreas2: 25–33 ArticleCASPubMed Google Scholar
Elstner E, Campbell MJ, Munker R, Shintaku P, Binderup L, Heber D, Said J and Koeffler HP (2000) Novel 20-epi-vitamin D analog combined with 9- cis -retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate40: 141–149 Article Google Scholar
Evans RM (1998) The steroid and thyroid hormone receptor superfamily. Science240: 889–895 Article Google Scholar
Evans TRJ, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG and Knight MJ (1996) A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer73: 1260–1264 ArticleCASPubMedPubMed Central Google Scholar
Gansauge S, Gansauge F and Beger HG (1996) Molecular oncology in pancreatic cancer. J Mol Med74: 313–320 ArticleCASPubMed Google Scholar
Gartel AL and Tyner AL (2000) Transcriptional regulation of the p21(WAF1/CIP1)gene. Exp Cell Res246: 280–289 Article Google Scholar
Giguere V, Ong ES, Segui P and Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature330: 624–629 ArticleCASPubMed Google Scholar
Haussler MR, Jurutka PW, Hsieh J-C, Thompson PD, Selznick SH, Haussler CA and Whitfield GK (1995) New understanding of the molecular mechanisms of receptor-mediated genomic actions of the vitamin D hormone. Bone17: 33S–38S ArticleCASPubMed Google Scholar
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE and Jurutka PW (1998) The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Min Res13: 325–342 ArticleCAS Google Scholar
Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell68: 397–406 ArticleCASPubMed Google Scholar
James SY, Mackay AG and Colston KW (1995) Vitamin D derivatives in combination with 9-cis-retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol14: 391–394 ArticleCASPubMed Google Scholar
James SY, Mercer E, Brady M Binderup L and Colston KW (1998) EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol125: 953–962 ArticleCASPubMedPubMed Central Google Scholar
James SY, Williams MA, Newland AC and Colston KW (2000) Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol32: 143–154 Article Google Scholar
Kaiser A, Wolf-Breitinger M, Albers A, Dorbic T, Wittig B, Riecken EO and Rosewicz S (1998) Retinoic acid receptor gamma-1 expression determines retinoid sensitivity in pancreatic carcinoma cells. Gastroenterology115: 967–977 ArticleCASPubMed Google Scholar
Kane KF, Langman MJS and Williams GR (1996) Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis-retinoic acid. Cancer Res56: 623–632 CASPubMed Google Scholar
Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T, Nikaido T and Furihata K (1996) Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology110: 1605–1613 ArticleCASPubMed Google Scholar
Kawa S, Nikaido T, Zhai Y, Kumagai T, Furihata K, Fujii S and Kiyosawa K (1997) Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer76: 884–889 ArticleCASPubMedPubMed Central Google Scholar
Kliewer SA, Umesono K, Mangelsdorf DJ and Evans RM (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature355: 446–449 ArticleCASPubMedPubMed Central Google Scholar
Korsmeyer SJ (2000) BCL-2 gene family and the regulation of programmed cell death. Cancer Res59: 1693s–1700s Google Scholar
Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M and Koeffler HP (2000) Combination therapy of a vitamin D analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res19: 519–524 Google Scholar
Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck G, Kratzeisen C, Rosenberger M & Lovey A Grippo JF (1992) 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature355: 359–361 ArticleCASPubMed Google Scholar
Liu M, Lee M-H, Cohen M, Bommakanti M and Freedman LP (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev10: 142–153 ArticleCASPubMed Google Scholar
Louvet C, Djelloul S, Forgue-Lafitte ME, Mester J, Zimber A and Gespach C (1996) Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha. Br J Cancer74: 394–399 ArticleCASPubMedPubMed Central Google Scholar
Mathiasen IS, Colston KW and Binderup L (1993) EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol46: 365–371 ArticleCASPubMed Google Scholar
Matsumoto T, Sowa Y, Ohtani-Fujita N, Tamaki T, Takenaka T, Kuribayashi K and Sakai T (1998) p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3. Cancer Lett129: 61–68 ArticleCASPubMed Google Scholar
Nagy L, Thomazy VA, Heyman RA and Davies PJ (1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ5: 11–19 ArticleCASPubMed Google Scholar
Okabe T, Yamaguchi N and Oshawa N (1983) Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas. Cancer51: 662–668 ArticleCASPubMed Google Scholar
Petkovich M, Brand NJ, Krust A and Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature330: 444–450 ArticleCASPubMed Google Scholar
Philpott NJ, Turner AJ, Scopes J, Westby M, Marsh JC, Gordon-Smith EC, Dalgleish AG and Gibson AG (1996) The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood87: 2244–2251 CASPubMed Google Scholar
Rosewicz S, Stier U, Brembeck F, Wiedenmann B and Riecken EO (1995) Retinoids: effect on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology109: 1646–1660 ArticleCASPubMed Google Scholar
Rothenberg ML, Moore MJ, Cripps MC, Andersen,, Portenoy RK, Burris HA, Green MR, Tarassoff PG, Brown TD, Casper ES, Stornioli AM and Von Hoff DD (1996) A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol7: 247–253 Article Google Scholar
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesh H, Kenney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst82: 1107–1112 ArticleCASPubMed Google Scholar
Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HD and Chu TM (1986) Characterization of a new primary human pancreatic tumour line. Cancer Invest4: 15–23 ArticleCASPubMed Google Scholar
Wang QM, Jones JB and Studzinski GP (1996) Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res56: 264–267 CASPubMed Google Scholar
Wang X and Studzinski GP (1997) Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res235: 210–217 ArticleCASPubMed Google Scholar
Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K and Knabbe C (1996) Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer73: 1341–1346 ArticleCASPubMedPubMed Central Google Scholar